206 results
6-K
EX-99
BLRX
Bioline Rx Ltd
10 Nov 14
BioLineRx Reports Third Quarter 2014 Financial Results
12:00am
and collaboration agreements.
Research and Development
Our research and development expenses consist primarily of salaries and related personnel expenses, fees … and development expenses to operations as they are incurred. We expect our research and development expense to remain our primary expense in the near future
6-K
EX-99
BLRX
Bioline Rx Ltd
8 Nov 18
BioLineRx Reports Significant Progress Across Oncology
7:00am
. We will have full access to all clinical and research and development data, as well as manufacturing data, generated during the performance … potential collaboration arrangements, including future royalties on product sales.
Research and Development
Our research and development expenses
6-K
EX-99
BLRX
Bioline Rx Ltd
28 Nov 11
BioLineRx Reports Third Quarter 2011 Financial Results
12:00am
with Ikaria, as well as under any future agreement relating to BL-1020, BL-1021, BL-5010, BL-7040 or other compounds.
Research and Development
Our … research and development expenses consist primarily of salaries and related personnel expenses, fees paid to external service providers, up-front
6-K
EX-99
BLRX
Bioline Rx Ltd
7 May 13
BioLineRx Reports First Quarter 2013 Results
12:00am
that planned research and development expenses will decrease for the remainder of 2013 and part of 2014 by approximately $6 to $7 million, thus allowing our … as under any future agreement relating to BL-1020, BL-5010, BL-7040, BL-8040, BL-1021, BL-8020 or other compounds.
Research and Development
Our research
6-K
EX-99
BLRX
Bioline Rx Ltd
15 Aug 12
BioLineRx Reports Second Quarter 2012 Results
12:00am
agreement relating to BL-1020, BL-1021, BL-5010, BL-7040 or other compounds.
Research and Development
Our research and development expenses consist … and clinical development work. We charge all research and development expenses to operations as they are incurred. We expect our research and development
6-K
EX-99
h1zzm
6 Aug 13
BioLineRx Reports Second Quarter 2013 Results
12:00am
6-K
EX-99
7n16ffxv
6 Aug 19
BioLineRx Reports Second Quarter 2019 Financial Results
7:11am
6-K
EX-99
pug2v lvkrx9f
14 May 19
BioLineRx Reports First Quarter 2019 Financial Results
7:00am
6-K
EX-99
lwszhzxa9k5rbwn
22 May 18
BioLineRx Reports First Quarter 2018 Financial Results
7:00am
6-K
EX-99
uqha7juda7vjvl6q
6 Aug 14
BioLineRx Reports Second Quarter 2014 Financial Results
12:00am
6-K
EX-99
gao ozltfg6y8l5lmzn
13 Aug 18
BioLineRx Reports Second Quarter 2018 Financial Results
7:01am
6-K
EX-99
zx1t7pr8i
16 Aug 22
BioLineRx Reports Second Quarter 2022 Financial Results
7:19am
6-K
EX-99
xz4 2tmxymrdf2e9o
20 May 14
BioLineRx Reports First Quarter 2014 Financial Results
12:00am
6-K
EX-99
vcxojgfsu c2
11 May 22
BioLineRx Reports First Quarter 2022 Financial Results
7:14am
6-K
EX-99
ocm8j0msl6c5h qg
20 May 20
BioLineRx Reports First Quarter 2020 Financial Results
7:00am
6-K
EX-99
mnsgjhb1wwh8l50ed0d
18 Nov 21
BioLineRx Reports Third Quarter 2021 Financial Results
7:16am
6-K
EX-99
nn7m7 qzyff0nh
15 Nov 22
BioLineRx Reports Third Quarter 2022 Financial Results and Recent Corporate
7:07am
6-K
EX-3
g4yzruj7r2cri500
12 Nov 19
Current report (foreign)
6:21am
6-K
EX-99
dy1w5mi 0i760g18
26 May 21
BioLineRx Reports First Quarter 2021 Financial Results
7:54am
6-K
EX-99
o195 55o3
23 Nov 20
BioLineRx Reports Third Quarter 2020 Financial Results
7:08am